Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes
NHS hospitals in England used £19,490,215 of indicative cost of Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 7.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| B'ham & S'hull Mh Nhs Foundation Trust | £1,189,707 |
| South London & Maudsley Nhs Found Trust | £959,206 |
| North London Nhs Foundation Trust | £948,239 |
| East London Nhs Foundation Trust | £926,225 |
| Sussex Partnership Nhs Foundation Trust | £907,798 |
| Essex Partnership University Nhs Ft | £874,006 |
| Ctrl & N W London Nhs Foundation Trust | £862,647 |
| Nottinghamshire Healthcare Nhs F Trust | £719,702 |
| Avon & Wiltshire Mental Hlth P/Ship Trst | £717,347 |
| Greater Manchester Mental Health Nhs Ft | £638,407 |
The primary-care picture
Paliperidone is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Paliperidone medicine page.